Aspects of postherpetic neuralgia: Can we zap Z-aP?

Pain Reviews

Volumn 3, Issue 2, 1996, Pages 117-135

  Johnson, Robert W ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; CAPSAICIN; DESIPRAMINE; EMLA; KETAMINE; LIDOCAINE; MAPROTILINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PRILOCAINE; STEROID; ZIMELDINE;

ANALGESIA; HERPES ZOSTER; HUMAN; POSTHERPETIC NEURALGIA; REVIEW; VARICELLA ZOSTER VIRUS;

EID: 0029741608     PISSN: 09681302     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (124)

1. von Bokay J. Uber den atiologischen Zusammenhang der Varizellen mit gewissen Fallen von Herpes zoster. Wien Klin Wochenschr 1909; 22 1323-26.
2. Weller TH, Coons AH. Fluorescent antibody studies with agents of varicella and herpes zoster propagated in vitro. Proc Soc Exp Biol Med 1954; 86: 789-94.
3. Weller TH, Witton HM, Bell EJ. The etiologic agents of varicella and herpes zoster. J Exp Med 1958; 108: 843-68.
4. Harding SP, Porter SM. Oral acyclovir in herpes zoster ophthalmicus. Curr Eye Res 1991; 10: 177-82.
5. Marsh RJ, Cooper M. Ophthalmic herpes zoster. Eye 1993; 7: 350-70.
6. Harding SP. Acyclovir and post-herpetic neuralgia. The balance of available evidence supports its use [Letter]. Br Med J 1995; 310: 1005.
7. Martinez-Martin P, Estevez E, Rapun JL, Echeverria JM, Garcia-Saiz A. Clusters of shingles [Letter]. Lancet 1985; ii: 1433-34.
8. Peto TEA, Gilks CF, Juel-Jensen BE. Clusters of shingles [Letter]. Lancet 1985; ii: 1433.
9. Shingles: a belt of roses from hell [Editorial]. Br Med J 1979; i: 5.
10. Grose C. Varicella-zoster virus infections. In: Glaser R, Gotlieb-Stematsky T, eds. Human herpesvirus infections. New York: Dekker, 1982: 85-150.
11. Dworkin RH, Portenoy RK. Proposed classification of herpes zoster pain [Letter]. Lancet 1994; 343: 1648.
12. Gilden DH, Dueland AN, Cohrs R, Martin JR, Kleinschmidt-DeMasters BK, Mahalingam R. Preherpetic neuralgia. Neurology 1991; 41: 1215-18.
13. Gilden DH, Wright RR, Schneck SA, Gwaltney JM, Mahalingam R. Zoster sine herpete, a clinical variant. Ann Neurol 1994; 35: 530-33.
14. de Moragas M, Kierland RR. The outcome of patients with herpes zoster. AMA Arch Dermatol 1957; 75: 193-96.
15. Hope-Simpson RE. Postherpetic neuralgia. J R Coll Gen Pract 1975; 25: 571-75.
16. Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 1965; 58: 9-20.
17. McGregor RM. Herpes zoster, chicken-pox and cancer in general practice. Br Med J 1957; i: 84-87.
18. Ragozzino MW, Melton LJ, Kurland LT, Chu CP, Perry HO. Population-based study of herpes zoster and its sequelae. Medicine 1982; 61: 310-16.
19. Oxman MN. Immunization to reduce the frequency and severity of herpes zoster and its complications. Neurology 1995; 45: 41-46.
20. Schmader K, Studenski S, Macmillan J, Grufferman S, Cohen HJ. Are stressful life events risk factors for herpes zoster? Am Geriatr Soc 1990; 38: 1188-94.
21. Pollock JI. The epidemiology of chickenpox. Infect Dis 1995; 9: 103-10.
22. Rowbotham MC, Fields HL. Post-herpetic neuralgia: the relation of pain complaint, sensory disturbance, and skin temperature. Pain: 1989; 39: 129-44.
23. Nurmikko T, Bowsher D. Somatosensory findings in postherpetic neuralgia. J Neural Neurosurg Psychiatry 1990; 53: 135-41.
24. Nurmikko T, Wells C, Bowsher D. Pain and allodynia in postherpetic neuralgia: role of somatic and sympathetic systems. Acta Neurol Scand 1991; 84: 146-52.
25. Leijon G, Boivie J, Rosberg M, Forsberg P. Sensory abnormalities accompanying herpes zoster and post-herpetic neuralgia [Abstract]. 7th World Congress on Pain, Seattle: IASP Press, 1993: P185.
26. Nurmikko T. Clinical features and pathophysiologic mechanisms of postherpetic neuralgia. Neurology 1995; 45: 54-55.
27. Noordenbos W. Pain. Amsterdam: Elsevier, 1959: 4-10.
28. Watson CPN, Deck JH, Morshead C, Van der Kooy D, Evans RJ. Post-herpetic neuralgia: further post-mortem studies of cases with and without pain. Pain 1991; 44: 105-17.
29. Beutner KR, Friedman DJ, Forszpaniak C, Andersen PL, Wood MJ. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 1995; 39: 1546-52.
30. Dworkin RH. Postherpetic neuralgia: impact of famciclovir treatment, pain severity and other risk factors in acute herpes zoster patients [Abstract]. American Pain Society Annual Meeting. 1995: Los Angeles (CA).
31. Dworkin RH, Hartstein G, Rosner HL, Walther RR, Sweeney EW, Brand L. A high-risk method for studying psychosocial antecedents of chronic pain: the prospective investigation of herpes zoster. J Abnorm Psychol 1992; 101: 1-20.
32. Dworkin RH, Cooper EM, Walther RR, Sweeney EW. Predicting the development of postherpetic neuralgia in acute herpes zoster patients: a diathesis-stress model. American Pain Society Annual Meeting. 1995: Los Angeles.
33. Esmann V, Peterslund NA, Ipsen J. Systematic antiviral treatment of herpes zoster. In: Spitzy KH, Karrer K editors. Proceedings of the 13th International Congress of Chemotherapy; 1983: Vienna; Part 39.
34. Eaglstein WH, Katz R, Brown JA. The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA 1970; 211: 1681-83.
35. Esmann V, Geil JP, Kroon S. Prednisolone does not prevent postherpetic neuralgia. Lancet 1987; ii: 126-29.
36. Keczkes K, Basheer AM. Do corticosteroids prevent postherpetic neuralgia? Br J Dermatol 1980; 102: 551-55.
37. Wood MJ, Johnson RW, McKendrick MW, Taylor J, Mandal BK, Crooks J. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 1994; 330: 896-900.
38. Whitley RJ, Weiss H, Guann J et al. and the NIAID Collaborative Antiviral Study Group. The efficacy of steroids and acyclovir therapy of herpes zoster in the elderly. Antiviral Res 1995; 26: A303.
39. Jenkner FL. Electric pain control. Vienna: Springer-Verlag, 1995: 233.
40. Manabe H, Dan K, Higa K. Continuous epidural infusion of local anaesthetics and shorter duration of acute zoster-associated pain. Clin J Pain 1995; 11: 220-28.
41. Winnie AP, Hartwell PW. Relationship between time of treatment of acute herpes zoster with sympathetic blockade and prevention of post-herpetic neuralgia: clinical support for a new theory of the mechanism by which sympathetic blockade provides therapeutic benefit. Reg Anesth 1993; 18: 277-82.
42. Currey TA, Dalsania J. Treatment for herpes zoster ophthalmicus: stellate ganglion block as a treatment for acute pain and prevention of postherpetic neuralgia. Ann Ophthalmol 1991; 23: 188-89.
43. Tenicela R, Lovasic D, Eaglstein W. Treatment of herpes zoster with sympathetic blocks. Clin J Pain 1985; 1: 63-67.
44. Ali NM. Does sympathetic ganglionic block prevent postherpetic neuralgia [Review]? Reg Anesth 1995; 20: 227-33.
45. Balfour HH, Bean B, Laskin OL, et al. Acyclovir for varicella zoster infection. N Engl J Med 1984; 310: 988.
46. Bean B, Aeppli D, Balfour HH. Acyclovir in shingles. J Antimicrob Chemother 1983; 12: 123-27.
47. Huff JC, Bean B, Balfour HH, et al. Therapy of herpes zoster with oral acyclovir. Am J Med 1988; 85: 84-89.
48. Juel-Jensen BE, Khan JA, Pasvol G. High-dose intravenous acyclovir in the treatment of zoster: a double-blind, placebo-controlled trial. J Infect 1983; 6: 31-36.
49. McKendrick MW, Care C, Burke C, Hickmott E, McKendrick GDW. Oral acyclovir in herpes zoster. J Antimicrob Chemother 1984; 14: 661-65.
50. Morton P, Thomson AN. Oral acyclovir in the treatment of herpes zoster in general practice. N Z J Med 1989; 102: 93-95.
51. Johnson RW. The future of predictors, prevention and therapy in postherpetic neuralgia. Neurology 1995; 45 (12 suppl 8): S70-S72.
52. Lancaster T, Silagy S, Gray S. Primary care management of acute herpes zoster: systematic review of evidence from randomized controlled trials. Br J Gen Pract 1995; 45: 39-45.
53. McKendrick MW, Wood MJ. Acyclovir and post-herpetic neuralgia [Letter]. Two other participating study centres report different results. Br Med J 1995; 310: 1005.
54. McGill JI, White JE. Prevention of herpes zoster-induced post-herpetic neuralgia and ocular involvement with acyclovir [Poster]. 2nd International Conference on the Varicella Zoster Virus. 1994 July; Paris.
55. McKendrick MW, Care C, Wood MJ, Ogan P. A retrospective review of herpes zoster and the development of chronic pain. Proceedings of the Second International Conference on the Varicella-Zoster Virus; 1994: Paris.
56. Juel-Jensen BE, MacCallum FO, MacKenzie AMR, Pike MC. Treatment of zoster with idoxuridine in dimethyl sulphoxide: results of two double-blind controlled trials. Br Med J 1970; iv: 776-80.
57. Neoh C, Harding SP, Saunders D, et al. Comparison of topical and oral acyclovir in early herpes zoster ophthalmicus. Eye 1994; 8: 688-91.
58. Marsh RJ, Cooper M. Double-masked trial of topical acyclovir and steroids in the treatment of herpes zoster ocular inflammation. Br J Ophthalmol 1991; 75: 542-46.
59. Bowsher D. Acute herpes zoster and postherpetic neuralgia: effects of acyclovir and outcome of treatment with amitriptyline. Br J Gen Pract 1992; 42: 244-46.
60. Bowsher D. The effects of acyclovir therapy for herpes zoster on treatment outcome in postherpetic neuralgia. Eur J Pain 1994; 15: 9-12.
61. Bowsher D. Pathophysiology of postherpetic neuralgia: towards a rational treatment. Neurology 1995; 45 (suppl 8): S56-S57.
62. Johnson RW, Mandal BK. Guidelines for the management of shingles. Report of a working group of the British Society for the Study of Infection. J Infect 1995; 30: 193-200.
63. International Herpes Management Forum. Reducing the burden of zoster-associated pain - update. IHMF Management Strategies Workshop, Orlando, FL, 1995. (IHMF and University of Alabama School of Medicine; PPS Europe Limited, Wicker House, High Street, Worthing. BN11 1DJ, UK.)
64. Carrington D, Johnson RW, Leen CLS, et al. Shingles: management guidance for general practice. London: Synergy Medical Education, 1994.
65. Davies L, Cossins L, Bowsher D, Drummond M. The cost of treatment for post-herpetic neuralgia in the UK. PharmacoEconomics 1994; 6: 142-48.
66. Johnson R, Shukla S, Fletcher P. Qualitative aspects of zoster-associated pain - evaluation of a new approach. 1st Scientific Meeting of the European Federation of IASP Chapters; 1995; Verona, Italy.
67. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acute Psychiatr Scand 1983; 67: 361-70.
68. Nathan PW, Wall PD. Treatment of postherpetic neuralgia by prolonged electrical stimulation. Br Med J 1974; 3: 645-47.
69. Haas LF. Postherpetic neuralgia. Trans Ophthalmol Soc N Z 1977; 29: 133-36.
70. Gerson GR, Jones RB, Luscombe DK. Studies of the concomitant use of carbamazepine and clomipramine for the relief of postherpetic neuralgia. Postgrad Med J 1977; 54: 104-109.
71. Payne C. Ultrasound for post-herpetic neuralgia. Physiotherapy 1984; 70: 96-97.
72. Jones RJ, Silman GM. Trials of ultrasonic therapy for acute herpes zoster. Practitioner 1987; 231: 1336-40.
73. Lewith GT, Field F, Machin D. Acupuncture versus placebo in postherpetic pain. Pain 1983; 17: 361-68.
74. Dung HC. Acupuncture for the treatment of post-herpetic neuralgia. Am J Acupunct 1987; 15: 5-14.
75. Stow PJ, Glynn CJ, Minor B. EMLA cream in the treatment of postherpetic neuralgia: efficacy and pharmacokinetic profile. Pain 1989; 39: 301-305.
76. Kissin I, McDanal J, Xavier AV. Topical lidocaine for relief of superficial pain in postherpetic neuralgia. Neurology 1989; 39: 1132-33.
77. Rowbotham MC, Fields HL. Topical lidocaine reduces pain in post-herpetic neuralgia. Pain 1989; 38: 297-301.
78. Wheeler JG. EMLA cream and herpetic neuralgia [Letter]. Med J Aust 1991; 154: 781.
79. Collins PD. EMLA cream and herpetic neuralgia. Med J Aust 1991; 155: 206-207.
80. Riopelle J, Lopez AA, Cork RC, et al. Treatment of cutaneous pain of acute herpes zoster with 9% lidocaine in petrolatum/paraffin ointment. J Am Acad Dermatol 1994; 30: 757-67.
81. Rowbotham MC, Miller KV, Davies P. Topical lidocaine for post-herpetic neuralgia pain: results of a double-blind, vehicle controlled trial. Neurology 1992; 42: 390.
82. Rowbotham MC, Reisner-Keller LA, Fields HL. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 1991; 41: 1024-28.
83. Alexander JI. Postherpetic neuralgia. Anaesthesia 1985; 40: 1133.
84. Coniam SW, Hunton J. A study of benzydamine cream in post-herpetic neuralgia. Res Clin Forums 1988; 10: 65-67.
85. McQuay HJ, Carroll D, Moxon A, Glynn CJ, Moore RA. Benzydamine cream for the treatment of post-herpetic neuralgia: minimum duration of treatment periods in a cross-over trial. Pain 1990; 40: 131-35.
86. Watson CPN, Tyler KL, Bickers DR, Millikan LE, Smith S, Coleman E. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther 1993; 15: 510-26.
87. Wall PD. Possible mechanisms of PHN. In: Watson CPN, ed. Herpes zoster and postherpetic neuralgia. Amsterdam: Elsevier, 1993: 123-38.
88. King RB. Concerning the management of pain associated with herpes zoster and of postherpetic neuralgia. Pain 1988; 33: 73-78.
89. Haines DR. Topical aspirin in chloroform for post-herpetic neuralgia. J Intractable Pain Soc 1989; 7: 15-16.
90. Max MB. Treatment of post-herpetic neuralgia: antidepressants. Ann Neurol 1994; 35: 50-53.
91. Max MB, Schafer SC, Culnane M et al. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology 1988; 38: 1427-32.
92. Watson CP, Evans RJ, Reed K, Merskey H, Goldsmith L, Warsh J. Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982; 32: 671-73.
93. Kishore-Kumar R, Max MB, Schafer SC. Desipramine relieves postherpetic neuralgia. Clin Pharmacol Ther 1990; 47: 305-12.
94. Watson CPN, Chipman M, Reed K. Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized double-blind, crossover trial. Pain 1992; 23: 387-94.
95. Watson CPN, Evans RJ. A comparative trial of amitriptyline and zimelidine in post-herpetic neuralgia. Pain 1985; 23: 387-94.
96. McQuay H, Carroll D, Jadad AR, Wiffen P, Moore A. Anticonvulsant drugs for the management of pain: a systematic review. Br Med J 1995; 311: 1047-52.
97. Watson CPN. The medical treatment of postherpetic neuralgia: antidepressants, other therapies and practical guidelines for management. In: Watson CPN editor. Herpes zoster and postherpetic neuralgia. Amsterdam: Elsevier, 1993: 212.
98. Killian JM, Fromm GH. Carbamazepine in the treatment of neuralgia. Arch Neurol 1968; 19: 129-36.
99. Hatangdi VS, Boas RA, Richards EG. Postherpetic neuralgia: management with antiepileptic tricyclic drugs. In: Bonica JJ, Albe-Fessard D, editors. Advances in pain research and therapy, vol. 1. New York: Raven Press, 1976: 583-87.
100. Raftery H. The management of postherpetic pain using sodium valproate and amitriptyline. Ir Med J 1979; 72: 399-401.
101. Rowbotham MC. Managing post-herpetic neuralgia with opioids and local anesthetics. Ann Neurol 1994; 35: 46-49.
102. Pappagallo M, Campbell JN. Chronic opioid therapy as alternative treatment for post-herpetic neuralgia. Ann Neurol 1994; 35: 54-56.
103. Hoffmann V, Coppejans H, Vercauteren M, Adriaensen HF. Successful treatment of postherpetic neuralgia with oral ketamine. Clin J Pain 1994; 10: 240-42.
104. Eide PK, Jorum E, Stubhaug A, Bremnes J, Breivik H. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind cross-over comparison with morphine and placebo. Pain 1994; 58: 347-54.
105. Bushnell T, Vijay V, Thwaites R, Tidy L, Hester J. Ketamine is an analgesic in refractory postherpetic neuralgia. J Pain Soc 1996; 12: in press.
106. Backonja M, Arndt G, Gombar KA, Check B, Zimmermann M. Response of chronic neuropathic pain syndromes to ketamine: a preliminary study. Pain 1994; 56: 51-57.
107. Kato Y, Homma I, Ichiyanagi K. Postherpetic neuralgia. Pain 1995; 11: 336-37.
108. Kristensen JD, Svensson B, Gordh T. The NMDA-receptor antagonist CPP abolishes neurogenic 'wind-up pain' after intrathecal administration in humans. Pain 1992; 51: 249-53.
109. McQuay HJ, Carroll D, Jada AR et al. Dextromethorphan for the treatment of neuropathic pain: a double-blind, randomised controlled crossover trial with integral n-of-1 design. Pain 1994; 59: 127-33.
110. Parkes D. Amantadine. Adv Drug Res 1975; 8: 11-81.
111. Galbraith AW. Treatment of acute herpes zoster with amantadine hydrochloride (Symmetrel). Br Med J 1973; 4: 693-95.
112. Sherlock CH, Corey L. Adenosine monophosphate for the treatment of varicella zoster infections: a large dose of caution. JAMA 1985; 253: 1444-45.
113. Sklar SH, Blue WT, Alexander EJ, Bodian CA. Herpes zoster: the treatment and prevention of neuralgia with adenosine monophosphate. JAMA 1985; 253: 1427-45.
114. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992; 326: 1250-56.
115. Csillik B, Knyihar-Csillik E, Szucs A. Treatment of chronic pain syndromes with iontophoresis of vinca alkaloids to the skin of patients. Neuroscience 1982; 31: 87-90.
116. Ikebe H, Miyagawa A, Mizutani A, Miyamoto M, Taniguchi K, Honda N. The effect of iontophoresis with several Ca channel blockers for PHN patients. Masui 1995; 44: 428-33.
117. De Benedittis G, Besana F, Lorenzetti A. A new topical treatment for acute herpetic neuralgia and postherpetic neuralgia: the aspirin/diethyl ether mixture: an open-label study plus a double-blind, controlled clinical trial. Pain 1992; 48: 383-90.
118. Reiestad F, Kvalheim L, McIlvaine WB. Pleural analgesia for the treatment of acute severe thoracic herpes zoster. Reg Anesth 1989; 14: 244-46.
119. Reiestad F, McIlvaine WB, Barnes M, Kvalheim L, Haraldstad MD, Pettersen B. Interpleural analgesia in the treatement of severe thoracic postherpetic neuralgia. Reg Anesth 1990; 15: 113-17.
120. Thwaites BK, Powell DR. Interpleural block for acute combined cervical and thoracic herpes zoster [Letter]. Reg Anesth 1995; 20: 255-56.
121. Sugar O, Bucy PC. Post-herpetic trigeminal neuralgia. Arch Neurol Psychiatry 1951; 65: 131.
122. Gybels JM, Sweet WH. Neurosurgical treatment of persistent pain: physiological and pathological mechanisms of human pain. In; Gildenberg PL, ed. Pain and headache. Basel: Karger, 1989: 118, 203-206, 217, 251, 311.
123. Friedman AH, Nashold BS, Ovelinen-Levitt J. Dorsal root entry zone lesions for the treatment of postherpetic neuralgia. J Neurosurg 1984; 60: 1258-62.
124. Friedman AH, Bullitt E. Dorsal root entry zone lesions in the treatment of pain following brachial plexus avulsion, spinal cord injury and herpes zoster. Appl Neurophysiol 1988; 51: 164-69.